Cargando…
Engineered and banked iPSCs for advanced NK- and T-cell immunotherapies
The development of methods to derive induced pluripotent stem cells (iPSCs) has propelled stem cell research, and has the potential to revolutionize many areas of medicine, including cancer immunotherapy. These cells can be propagated limitlessly and can differentiate into nearly any specialized cel...
Autores principales: | Cichocki, Frank, van der Stegen, Sjoukje J. C., Miller, Jeffrey S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10023718/ https://www.ncbi.nlm.nih.gov/pubmed/36327161 http://dx.doi.org/10.1182/blood.2022016205 |
Ejemplares similares
-
Banking on virus-specific T cells to fulfill the need for off-the-shelf cell therapies
por: Quach, David H., et al.
Publicado: (2023) -
Allogeneic natural killer cell therapy
por: Berrien-Elliott, Melissa M., et al.
Publicado: (2023) -
Genome-edited allogeneic donor “universal” chimeric antigen receptor T cells
por: Qasim, Waseem
Publicado: (2023) -
Eye banking: an introduction
por: Rao, Gullapalli N, et al.
Publicado: (2009) -
Creation of GMP-Compliant iPSCs From Banked Umbilical Cord Blood
por: Tian, Pei, et al.
Publicado: (2022)